Resistance in viruses other than HIV.
The aim of this brief paper is to summarize the ways in which viruses develop resistance to currently licensed anti-viral drugs and to comment on their clinical relevance. Specific examples will be chosen to emphasize basic principles of the development of resistance and readers are referred elsewhere to a summary of resistance in HIV that follows the same principles.
Griffiths
Paul D
PD
Royal Free and University College Medical School of UCL, London, UK. p.griffiths@rfc.ucl.ac.uk
D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000821:virology; D024882:Drug Resistance, Viral; D006509:Hepatitis B / Q000188:drug therapy / Q000821:virology; D006561:Herpes Simplex / Q000188:drug therapy / Q000821:virology; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy / Q000821:virology; D014777:Virus Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000821:virology*
D000998:Antiviral Agents